Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of Ginkgo biloba extract tablets for tinnitus after sudden deafness
ChiCTR2100043374Phase 4Not yet recruiting
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ginkgo biloba extract in tinnitus and acute sensorineural hearing loss (2 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoints: Tinnitus VAS score and Absolute change in tinnitus THI score. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
ginkgo biloba extract
03
Conditions
tinnitusacute sensorineural hearing loss
Beyond the preview
Go deeper on ChiCTR2100043374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043374.